Chronic treatment with silymarin nanoliposomes effectively ameliorated inflammation, OS, and renal fibrosis via inhibiting JAK2/STAT3/suppressor of cytokine signaling 1 and TGF‐β/Smad signaling pathways in diabetic rats with STZ‐induced kidney injury (Chen et al. 2021). Here, SOCS1 is linked to renal fibrosis.